NF symposium to focus on tumor disorders
The School of Medicine is home to an internationally renowned center for multidisciplinary research of neurofibromatosis and comprehensive care of patients affected by it. The university’s Neurofibromatosis Center will host a symposium May 16 that will bring together patients, their family members and researchers to discuss the latest insight into the diagnosis and treatment of NF.
Gender influences symptoms of genetic disorder
Researchers at Washington University School of Medicine in St. Louis have identified a patient’s gender as a clear and simple guidepost to help health care providers anticipate some of the otherwise unpredictable effects of neurofibromatosis type 1, a childhood genetic disorder.
Gutmann recognized for neurofibromatosis research
David H. Gutmann, MD, PhD, a neurofibromatosis expert
at the Siteman Cancer Center at Barnes-Jewish Hospital and Washington
University School of Medicine in St. Louis, has received the 2012
Friedrich von Recklinghausen Award.
Finding may help prevent vision loss in tumor disorder
Nerve cells in the body and brain react in opposite ways to the loss of a protein linked to a childhood tumor syndrome, researchers at Washington University School of Medicine in St. Louis have found. The finding could be important to efforts to preserve the vision of patients with neurofibromatosis 1, a genetic condition that increases risk of benign and malignant brain tumors.